299 related articles for article (PubMed ID: 32007596)
1. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.
Göbel A; Rauner M; Hofbauer LC; Rachner TD
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188351. PubMed ID: 32007596
[TBL] [Abstract][Full Text] [Related]
2. Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Thurnher M; Nussbaumer O; Gruenbacher G
Clin Cancer Res; 2012 Jul; 18(13):3524-31. PubMed ID: 22529099
[TBL] [Abstract][Full Text] [Related]
3. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
[TBL] [Abstract][Full Text] [Related]
4. Mevalonate Pathway and Human Cancers.
Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F
Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
[TBL] [Abstract][Full Text] [Related]
6. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.
Karlic H; Thaler R; Gerner C; Grunt T; Proestling K; Haider F; Varga F
Cancer Genet; 2015 May; 208(5):241-52. PubMed ID: 25978957
[TBL] [Abstract][Full Text] [Related]
8. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System.
Zhang C; Jin DD; Wang XY; Lou L; Yang J
J Cardiovasc Pharmacol; 2021 Feb; 77(2):142-152. PubMed ID: 33538531
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer therapy: targeting the mevalonate pathway.
Swanson KM; Hohl RJ
Curr Cancer Drug Targets; 2006 Feb; 6(1):15-37. PubMed ID: 16475974
[TBL] [Abstract][Full Text] [Related]
10. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application.
Jiao X; Ashtari N; Rahimi-Balaei M; Chen QM; Badbezanchi I; Shojaei S; Marzban A; Mirzaei N; Chung S; Guan T; Li J; Vriend J; Mehr SE; Kong J; Marzban H
Curr Mol Pharmacol; 2017; 10(2):115-140. PubMed ID: 26758948
[TBL] [Abstract][Full Text] [Related]
11. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
12. The mevalonate pathway in breast cancer biology.
Göbel A; Riffel RM; Hofbauer LC; Rachner TD
Cancer Lett; 2022 Aug; 542():215761. PubMed ID: 35640730
[TBL] [Abstract][Full Text] [Related]
13. Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
Muller AL; Freed DH
Curr Mol Pharmacol; 2017; 10(1):6-12. PubMed ID: 26758946
[TBL] [Abstract][Full Text] [Related]
14. Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Göbel A; Thiele S; Browne AJ; Rauner M; Zinna VM; Hofbauer LC; Rachner TD
Cancer Lett; 2016 May; 375(1):162-171. PubMed ID: 26968247
[TBL] [Abstract][Full Text] [Related]
15. Key roles of Rho GTPases, YAP, and Mutant P53 in anti-neoplastic effects of statins.
Ji L; Liu C; Yuan Y; Gao H; Tang ZX; Yang Z; Liu ZT; Jiang GH
Fundam Clin Pharmacol; 2020 Feb; 34(1):4-10. PubMed ID: 31241783
[TBL] [Abstract][Full Text] [Related]
16. Mevalonate pathway: a review of clinical and therapeutical implications.
Buhaescu I; Izzedine H
Clin Biochem; 2007 Jun; 40(9-10):575-84. PubMed ID: 17467679
[TBL] [Abstract][Full Text] [Related]
17. The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.
Bhardwaj A; Singh H; Trinidad CM; Albarracin CT; Hunt KK; Bedrosian I
Breast Cancer Res; 2018 Dec; 20(1):150. PubMed ID: 30537987
[TBL] [Abstract][Full Text] [Related]
18. Statins and protein prenylation in cancer cell biology and therapy.
Garcia-Ruiz C; Morales A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):303-15. PubMed ID: 22413970
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the mevalonate pathway ameliorates anoxia-induced down-regulation of FKBP12.6 and intracellular calcium handling dysfunction in H9c2 cells.
Yang Y; Lu X; Rong X; Jiang W; Lai D; Ma Y; Zhou K; Fu G; Xu S
J Mol Cell Cardiol; 2015 Mar; 80():166-74. PubMed ID: 25636197
[TBL] [Abstract][Full Text] [Related]
20. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
